Paul Abramowitz, PharmD, urged the president to wield the Public Readiness and Emergency Preparedness Act and authorize pharmacists to initiate medications for opioid use disorder and co-prescribe naloxone.
In the letter, Dr. Abramowitz also asked him to “allow physicians to bill for complex evaluation and management services when provided by a pharmacist incident to the physician,” grant prescribers the ability to initiate opioid use disorder medications through telehealth, and allow physicians the option to virtually supervise pharmacists. He seeks for the last two to be made permanent, as they are tied to the soon-to-expire federal COVID-19 public health emergency.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.